Blue Venture Fund

Type

CVC

Status

Active

Location

Chicago, United States

Total investments

88

Average round size

22M

Portfolio companies

52

Rounds per year

5.87

Lead investments

20

Follow on index

0.41

Exits

14

Stages of investment
SeedPrivate EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareHealth DiagnosticsHospitalWellnessMedicalHome Health CareRisk Management

Summary

The leading representative office of defined VC is situated in the Chicago. The company was established in North America in United States. BlueCross BlueShield Venture Partners appeared to be a CVC structure as part of the corporation.

The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 2-6 deals every year. Speaking about the real fund results, this VC is 17 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2013. The typical startup value when the investment from BlueCross BlueShield Venture Partners is 10-50 millions dollars. Opposing the other organizations, this BlueCross BlueShield Venture Partners works on 16 percentage points less the average amount of lead investments. The top amount of exits for fund were in 2019.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the BlueCross BlueShield Venture Partners, startups are often financed by HLM Venture Partners, SJF Ventures, Omidyar Network. The meaningful sponsors for the fund in investment in the same round are Healthbox, HCA, HLM Venture Partners. In the next rounds fund is usually obtained by HLM Venture Partners, SJF Ventures, Oak HC/FT.

Besides them, we counted 8 critical employees of this fund in our database.

Among the most successful fund investment fields, there are Hospital, Wellness. Among the most popular portfolio startups of the fund, we may highlight Theranos, Change Healthcare, Change Healthcare. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Show more

Investor highlights

Industry focus
HealthcareBiotech/Life Sciences
Stage focus
Generalist
Geo focus
Generalist
Check size
1M — 20M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
88
Lead investments
20
Exits
14
Rounds per year
5.87
Follow on index
0.41
Investments by industry
  • Health Care (74)
  • Medical (23)
  • Wellness (22)
  • Information Technology (22)
  • Hospital (19)
  • Show 49 more
Investments by region
  • United States (82)
  • United Kingdom (4)
  • India (2)
Peak activity year
2013
Number of Unicorns
2
Number of Decacorns
3
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
475M
Group Appearance index
0.90
Avg. company exit year
10
Avg. multiplicator
56.47
Strategy success index
0.60

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Capson 20 May 2010 Insurance Seed 13M United States, Texas, Austin
Workit Health 21 Oct 2021 Health Care, Hospital, Personal Health, Risk Management Late Stage Venture 90M United States, Ann Arbor, Michigan

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.